Matthew Hanley - Dissemin

All papers authored by Matthew Hanley

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

2023 Julia Rotow, Jyoti D. Patel, Matthew P. Hanley

, Helena Yu, Mark Awad, Jonathan W. Goldman, Hovav Nechushtan, Matthias Scheffler, Chih Hsi S. Kuo, Senthil Rajappa, Guilherme Harada, Sarah Clifford, Alison Santucci, Laura Silva, Rebecca Tupper and 3 other authors

Supplementary Figure S2 from Osimertinib and Selpercatinib Efficacy, Safety, and Resistance in a Multicenter, Prospectively Treated Cohort of EGFR-Mutant and RET Fusion-Positive Lung Cancers

Upload

Julia Rotow, Jyoti D. Patel, Matthew P. Hanley

Supplementary Table S4 from Osimertinib and Selpercatinib Efficacy, Safety, and Resistance in a Multicenter, Prospectively Treated Cohort of EGFR-Mutant and RET Fusion-Positive Lung Cancers

Upload

Julia Rotow, Jyoti D. Patel, Matthew P. Hanley

Supplementary Table S5 from Osimertinib and Selpercatinib Efficacy, Safety, and Resistance in a Multicenter, Prospectively Treated Cohort of EGFR-Mutant and RET Fusion-Positive Lung Cancers

Upload

Julia Rotow, Jyoti D. Patel, Matthew P. Hanley

Supplementary Table S8 from Osimertinib and Selpercatinib Efficacy, Safety, and Resistance in a Multicenter, Prospectively Treated Cohort of EGFR-Mutant and RET Fusion-Positive Lung Cancers

Upload

Julia Rotow, Jyoti D. Patel, Matthew P. Hanley

Supplementary Table S3 from Osimertinib and Selpercatinib Efficacy, Safety, and Resistance in a Multicenter, Prospectively Treated Cohort of EGFR-Mutant and RET Fusion-Positive Lung Cancers

Upload

Julia Rotow, Jyoti D. Patel, Matthew P. Hanley

Supplementary Table S2 from Osimertinib and Selpercatinib Efficacy, Safety, and Resistance in a Multicenter, Prospectively Treated Cohort of EGFR-Mutant and RET Fusion-Positive Lung Cancers

Upload

Julia Rotow, Jyoti D. Patel, Matthew P. Hanley

Supplementary Table S1 from Osimertinib and Selpercatinib Efficacy, Safety, and Resistance in a Multicenter, Prospectively Treated Cohort of EGFR-Mutant and RET Fusion-Positive Lung Cancers

Upload

Julia Rotow, Jyoti D. Patel, Matthew P. Hanley

Supplementary Table S6 from Osimertinib and Selpercatinib Efficacy, Safety, and Resistance in a Multicenter, Prospectively Treated Cohort of EGFR-Mutant and RET Fusion-Positive Lung Cancers

Upload

Julia Rotow, Jyoti D. Patel, Matthew P. Hanley

Supplementary Table S7 from Osimertinib and Selpercatinib Efficacy, Safety, and Resistance in a Multicenter, Prospectively Treated Cohort of EGFR-Mutant and RET Fusion-Positive Lung Cancers

Upload

Julia Rotow, Jyoti D. Patel, Matthew P. Hanley

Supplementary Figure S1 from Osimertinib and Selpercatinib Efficacy, Safety, and Resistance in a Multicenter, Prospectively Treated Cohort of EGFR-Mutant and RET Fusion-Positive Lung Cancers

Upload

Julia Rotow, Jyoti D. Patel, Matthew P. Hanley

Data from Osimertinib and Selpercatinib Efficacy, Safety, and Resistance in a Multicenter, Prospectively Treated Cohort of EGFR-Mutant and RET Fusion-Positive Lung Cancers

Upload

This paper was not found in any repository, but could be made available legally by the author.

Julia Rotow

, Jyoti D. Patel

, Matthew P. Hanley

, Helena Yu

, Mark Awad

, Jonathan W. Goldman

, Hovav Nechushtan

, Matthias Scheffler

, Chih-Hsi S. Kuo

, Senthil Rajappa

, Guilherme Harada

, Sarah Clifford

, Alison Santucci

, Laura Silva

, Rebecca Tupper

and 3 other authors

Osimertinib and Selpercatinib Efficacy, Safety, and Resistance in a Multicenter, Prospectively Treated Cohort of EGFR-Mutant and RET Fusion-Positive Lung Cancers

Upload

This paper is made freely available by the publisher.

2019 Matthew P. Hanley

, Oladimeji Aladelokun, Krishna Kadaveru, Daniel W. Rosenberg

Methyl Donor Deficiency Blocks Colorectal Cancer Development by Affecting Key Metabolic Pathways

Download from aacrjournals.org

2018 Allen Mo, Rong Wu, James P. Grady, Matthew P. Hanley

, Margaret Toro, Helen Swede, Thomas J. Devers, Terryl J. Hartman, Daniel W. Rosenberg

Associations of dietary fat with risk of early neoplasia in the proximal colon in a population-based case–control study

Download from link.springer.com

Payal Mittal, Rebecca Abblett

, Joseph M. Ryan

, Adam T. Hagymasi, Archibald Agyekum-Yamoah, Julia Svedova

, Steven L. Reiner

, Marie-Clare St. Rose, Matthew P. Hanley

, Anthony T. Vella, Adam J. Adler

An Immunotherapeutic CD137 Agonist Releases Eomesodermin from ThPOK Repression in CD4 T Cells

Download from journals.aai.org

2017 Masako Nakanishi, Matthew P. Hanley

, Ruochen Zha, Yuichi Igarashi, Mark A. Hull, Gary Mathias, Frank Sciavolino, James J. Grady, Daniel W. Rosenberg

A novel bioactive derivative of eicosapentaenoic acid (EPA) suppresses intestinal tumor development in ApcΔ14/+ mice

Upload

M. P. Hanley

, M. A. Hahn, A. X. Li, X. Wu, J. Lin, J. Wang, A. H. Choi, Z. Ouyang, Y. Fong, G. P. Pfeifer, T. J. Devers, D. W. Rosenberg

Genome-wide DNA methylation profiling reveals cancer-associated changes within early colonic neoplasia

Download from www.nature.com

2016 Matthew P. Hanley

, Krishna Kadaveru, Christine Perret, Charles Giardina, Daniel W. Rosenberg

Dietary Methyl Donor Depletion Suppresses Intestinal Adenoma Development

Download from aacrjournals.org

2015 Matthew P. Hanley

, Daniel W. Rosenberg

One-Carbon Metabolism and Colorectal Cancer: Potential Mechanisms of Chemoprevention

Download from link.springer.com

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

All papers authored by Matthew Hanley